PRT-2761
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRT-2761, covering 2022-10-17 to 2022-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis [Phase 2]